








{"id":1891,"date":"2020-06-16T16:09:32","date_gmt":"2020-06-16T16:09:32","guid":{"rendered":"https:\/\/adop.deltasolucoes.com\/?p=1891"},"modified":"2022-01-26T16:14:43","modified_gmt":"2022-01-26T16:14:43","slug":"a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list","status":"publish","type":"post","link":"https:\/\/adop.pt\/en\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/","title":{"rendered":"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d"},"content":{"rendered":"<p class=\"Predefinio\"><a href=\"https:\/\/adop.deltasolucoes.com\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1892 size-medium alignleft\" src=\"https:\/\/adop.deltasolucoes.com\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263-300x158.jpg\" alt=\"\" width=\"300\" height=\"158\" \/><\/a>A ADoP esteve representada pelo Diretor Executivo, Dr. Ant\u00f3nio J\u00falio Nunes, pela Respons\u00e1vel pelo Sistema de Localiza\u00e7\u00e3o, Dra. Sofia Neves e pelo Respons\u00e1vel pelo Programa de Educa\u00e7\u00e3o, Dr. Carlos Santos, no Webinar realizado pela ITA, onde foram abordados v\u00e1rios t\u00f3picos relacionados com os cuidados que os praticantes desportivos dever\u00e3o ter na administra\u00e7\u00e3o de medicamentos ou suplementos bem como na solicita\u00e7\u00e3o de uma Autoriza\u00e7\u00e3o de Utiliza\u00e7\u00e3o Terap\u00eautica (AUT).<\/p>\n<p class=\"Predefinio\">Foram preletores neste Webinar, a o farmac\u00eautico, Mark Stuart, a m\u00e9dica de medicina desportiva, Margo Mountjoy e o ex-jogador profissional de futebol australiano, Eric Mackenzie. Foi moderadora da sess\u00e3o a gestora do Programa de Educa\u00e7\u00e3o da ITA, Olya Abasolo.<\/p>\n<p class=\"Predefinio\">Mark Stuart real\u00e7ou o facto da lista de subst\u00e2ncias proibidas referir cerca de 200 subst\u00e2ncias o que obriga a um cuidado muito significativo por parte dos praticantes desportivos, visto que algumas s\u00e3o sempre proibidas, outras s\u00e3o proibidas somente em competi\u00e7\u00e3o e um terceiro grupo s\u00f3 s\u00e3o proibidas em alguns desportos. Alertou tamb\u00e9m para a situa\u00e7\u00e3o vivida com os suplementos, a qual \u00e9 muito perigosa para os praticantes desportivos visto que por vezes as composi\u00e7\u00f5es qu\u00edmicas que constam nas etiquetas n\u00e3o correspondem ao produto no interior da embalagem e ainda para as diferen\u00e7as significativas nas regras de produ\u00e7\u00e3o daqueles produtos.<\/p>\n<p class=\"Predefinio\">Eric Mackenzie, na sua qualidade de ex-jogador profissional de futebol australiano aproveitou para transmitir a sua experi\u00eancia pessoal, nomeadamente no que se refere \u00e0s les\u00f5es sofridas e necessidade de recorrer a alguns f\u00e1rmacos com subst\u00e2ncias que constavam da lista e outros f\u00e1rmacos inovadores, por exemplo com produtos habitualmente utilizados em animais. Deixou como conselhos o de n\u00e3o se tomar nada porque os outros tomam e consultar sempre o m\u00e9dico antes de tomar qualquer medicamento.<\/p>\n<p class=\"Predefinio\">Finalmente Margo Mountjoy abordou a quest\u00e3o das TUEs, ou seja Autoriza\u00e7\u00f5es de Utiliza\u00e7\u00e3o Terap\u00eautica \u2013 AUT referindo o que s\u00e3o, porque existem, quem est\u00e1 sujeito a elas, quando se devem solicitar e como se devem solicitar. Por fim deixou os seguintes conselhos:<\/p>\n<ul>\n<li class=\"Predefinio\">Avisar o m\u00e9dico da sua condi\u00e7\u00e3o de praticante desportivo;<\/li>\n<li class=\"Predefinio\">No formul\u00e1rio do Controlo de Doping, se for o caso, \u00a0referir que tem uma AUT;<\/li>\n<li class=\"Predefinio\">Manter um ficheiro m\u00e9dico individual atualizado.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>A ADoP esteve representada pelo Diretor Executivo, Dr. Ant\u00f3nio J\u00falio Nunes, pela Respons\u00e1vel pelo Sistema de Localiza\u00e7\u00e3o, Dra. Sofia Neves e pelo Respons\u00e1vel pelo Programa de Educa\u00e7\u00e3o, Dr. Carlos Santos no Webinar realizado pela International Testing Agency (ITA)<\/p>","protected":false},"author":7,"featured_media":1892,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1891","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sem-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d - ADoP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/adop.pt\/en\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d - ADoP\" \/>\n<meta property=\"og:description\" content=\"A ADoP esteve representada pelo Diretor Executivo, Dr. Ant\u00f3nio J\u00falio Nunes, pela Respons\u00e1vel pelo Sistema de Localiza\u00e7\u00e3o, Dra. Sofia Neves e pelo Respons\u00e1vel pelo Programa de Educa\u00e7\u00e3o, Dr. Carlos Santos no Webinar realizado pela International Testing Agency (ITA)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/adop.pt\/en\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/\" \/>\n<meta property=\"og:site_name\" content=\"ADoP\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61565720170060\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-16T16:09:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-26T16:14:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"263\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cesar.laranjo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cesar.laranjo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/\"},\"author\":{\"name\":\"cesar.laranjo\",\"@id\":\"https:\/\/adop.pt\/#\/schema\/person\/a6e9cbdf0772431261ac9bffb7978b82\"},\"headline\":\"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d\",\"datePublished\":\"2020-06-16T16:09:32+00:00\",\"dateModified\":\"2022-01-26T16:14:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/\"},\"wordCount\":411,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/adop.pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg\",\"articleSection\":[\"Sem categoria\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/\",\"url\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/\",\"name\":\"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d - ADoP\",\"isPartOf\":{\"@id\":\"https:\/\/adop.pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg\",\"datePublished\":\"2020-06-16T16:09:32+00:00\",\"dateModified\":\"2022-01-26T16:14:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage\",\"url\":\"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg\",\"contentUrl\":\"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg\",\"width\":500,\"height\":263},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/adop.pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/adop.pt\/#website\",\"url\":\"https:\/\/adop.pt\/\",\"name\":\"ADoP\",\"description\":\"Autoridade Antidopagem de Portugal\",\"publisher\":{\"@id\":\"https:\/\/adop.pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/adop.pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/adop.pt\/#organization\",\"name\":\"ADoP\",\"url\":\"https:\/\/adop.pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/adop.pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/adop.pt\/wp-content\/uploads\/2021\/11\/cropped-adop-logo-bg.jpg\",\"contentUrl\":\"https:\/\/adop.pt\/wp-content\/uploads\/2021\/11\/cropped-adop-logo-bg.jpg\",\"width\":512,\"height\":512,\"caption\":\"ADoP\"},\"image\":{\"@id\":\"https:\/\/adop.pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61565720170060\",\"https:\/\/www.instagram.com\/antidopagem\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/adop.pt\/#\/schema\/person\/a6e9cbdf0772431261ac9bffb7978b82\",\"name\":\"cesar.laranjo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/adop.pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b4f2162739a0f56788d59bb586731d24b41216b1f4bba5ede1255501e7eacaa6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b4f2162739a0f56788d59bb586731d24b41216b1f4bba5ede1255501e7eacaa6?s=96&d=mm&r=g\",\"caption\":\"cesar.laranjo\"},\"url\":\"https:\/\/adop.pt\/en\/author\/cesar-laranjo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d - ADoP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/adop.pt\/en\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/","og_locale":"en_GB","og_type":"article","og_title":"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d - ADoP","og_description":"A ADoP esteve representada pelo Diretor Executivo, Dr. Ant\u00f3nio J\u00falio Nunes, pela Respons\u00e1vel pelo Sistema de Localiza\u00e7\u00e3o, Dra. Sofia Neves e pelo Respons\u00e1vel pelo Programa de Educa\u00e7\u00e3o, Dr. Carlos Santos no Webinar realizado pela International Testing Agency (ITA)","og_url":"https:\/\/adop.pt\/en\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/","og_site_name":"ADoP","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61565720170060","article_published_time":"2020-06-16T16:09:32+00:00","article_modified_time":"2022-01-26T16:14:43+00:00","og_image":[{"width":500,"height":263,"url":"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg","type":"image\/jpeg"}],"author":"cesar.laranjo","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cesar.laranjo","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#article","isPartOf":{"@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/"},"author":{"name":"cesar.laranjo","@id":"https:\/\/adop.pt\/#\/schema\/person\/a6e9cbdf0772431261ac9bffb7978b82"},"headline":"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d","datePublished":"2020-06-16T16:09:32+00:00","dateModified":"2022-01-26T16:14:43+00:00","mainEntityOfPage":{"@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/"},"wordCount":411,"commentCount":0,"publisher":{"@id":"https:\/\/adop.pt\/#organization"},"image":{"@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage"},"thumbnailUrl":"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg","articleSection":["Sem categoria"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/","url":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/","name":"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d - ADoP","isPartOf":{"@id":"https:\/\/adop.pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage"},"image":{"@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage"},"thumbnailUrl":"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg","datePublished":"2020-06-16T16:09:32+00:00","dateModified":"2022-01-26T16:14:43+00:00","breadcrumb":{"@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#primaryimage","url":"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg","contentUrl":"https:\/\/adop.pt\/wp-content\/uploads\/2022\/01\/tue_-_ita_500x263.jpg","width":500,"height":263},{"@type":"BreadcrumbList","@id":"https:\/\/adop.pt\/a-adop-participou-num-webinar-da-ita-intitulado-medications-supplements-tues-and-the-prohibited-list\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/adop.pt\/"},{"@type":"ListItem","position":2,"name":"A ADoP participou num Webinar da ITA intitulado \u201cMedications, Supplements, TUEs and the Prohibited list\u201d"}]},{"@type":"WebSite","@id":"https:\/\/adop.pt\/#website","url":"https:\/\/adop.pt\/","name":"ADoP","description":"Autoridade Antidopagem de Portugal","publisher":{"@id":"https:\/\/adop.pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/adop.pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/adop.pt\/#organization","name":"ADoP","url":"https:\/\/adop.pt\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/adop.pt\/#\/schema\/logo\/image\/","url":"https:\/\/adop.pt\/wp-content\/uploads\/2021\/11\/cropped-adop-logo-bg.jpg","contentUrl":"https:\/\/adop.pt\/wp-content\/uploads\/2021\/11\/cropped-adop-logo-bg.jpg","width":512,"height":512,"caption":"ADoP"},"image":{"@id":"https:\/\/adop.pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61565720170060","https:\/\/www.instagram.com\/antidopagem\/"]},{"@type":"Person","@id":"https:\/\/adop.pt\/#\/schema\/person\/a6e9cbdf0772431261ac9bffb7978b82","name":"cesar.laranjo","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/adop.pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b4f2162739a0f56788d59bb586731d24b41216b1f4bba5ede1255501e7eacaa6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4f2162739a0f56788d59bb586731d24b41216b1f4bba5ede1255501e7eacaa6?s=96&d=mm&r=g","caption":"cesar.laranjo"},"url":"https:\/\/adop.pt\/en\/author\/cesar-laranjo\/"}]}},"_links":{"self":[{"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/posts\/1891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/comments?post=1891"}],"version-history":[{"count":1,"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/posts\/1891\/revisions"}],"predecessor-version":[{"id":1893,"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/posts\/1891\/revisions\/1893"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/media\/1892"}],"wp:attachment":[{"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/media?parent=1891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/categories?post=1891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adop.pt\/en\/wp-json\/wp\/v2\/tags?post=1891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}